Literature DB >> 16138885

New tools for the effective delivery of cardiac resynchronization therapy.

Angel R León1.   

Abstract

Cardiac resynchronization therapy (CRT) has been shown to provide symptom relief to many patients who have congestive heart failure (CHF). Still, there are technical concerns with implanting CRT systems, and these range from inadequate venous anatomy to a variety of left ventricular (LV) lead problems. Fortunately, there are several new implant tools to help physicians achieve a stable and adequate LV pacing site. There are a number of guiding catheter shapes to tailor the choice to specific anatomic abnormalities that may be encountered during implants. Key to success was the development of over-the-wire LV leads that are capable of maneuvering within complex venous anatomy. Improvements in LV leads have included increasing lead diameter and bipolar design. In some cases, epicardial LV lead placement may be necessary at surgery. The latest systems have begun to integrate disease management modalities, which hopefully will reduce the need for CHF hospitalizations.

Entities:  

Mesh:

Year:  2005        PMID: 16138885     DOI: 10.1111/j.1540-8167.2005.50186.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  3 in total

1.  Event-free survival following CRT with surgically implanted LV leads versus standard transvenous approach.

Authors:  Amy L Miller; Daniel B Kramer; Eldrin F Lewis; Bruce Koplan; Laurence M Epstein; Usha Tedrow
Journal:  Pacing Clin Electrophysiol       Date:  2011-04       Impact factor: 1.976

2.  The variable functional effects of the pacing site in normal and scarred ventricles.

Authors:  Luisa Muñoz del Romeral; Carol Stillson; Michael Lesh; Elias Botvinick
Journal:  J Nucl Cardiol       Date:  2009 Nov-Dec       Impact factor: 5.952

3.  Usefulness of Decapolar catheter via femoral approach on CS cannulation during CRT device implantation.

Authors:  Rajeev Sharma; Archit Dahiya; Piyush Joshi; Tushar Wadhawan; Harsh Wardhan
Journal:  J Arrhythm       Date:  2022-08-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.